Literature DB >> 7655023

Leukemia inhibitory factor induces interleukin-8 and monocyte chemotactic and activating factor in human monocytes: differential regulation by interferon-gamma.

T Musso1, R Badolato, D L Longo, G L Gusella, L Varesio.   

Abstract

Leukemia inhibitory factor (LIF) is a cytokine released at the site of injuries where there is a recruitment of monocytes and polymorphonuclear cells. We analyzed the effect of LIF on human monocytes, which are a major source of chemotactic factors. We showed that supernatants of monocytes treated with LIF (50 ng/mL) for 18 hours had chemotactic activity for neutrophils and monocytes that was neutralized by anti-interleukin-8 (anti-IL-8) and anti-monocyte chemotactic and activating factor (anti-MCAF) neutralizing antibodies. Northern blot analysis showed induction of IL-8 and MCAF RNA in monocytes treated with LIF. Both IL-8 and MCAF mRNA were induced within 3 hours of stimulation. IL-8 and MCAF mRNAs expression peaked at 6 hours and 18 hours, respectively. Interferon-gamma (IFN-gamma), a potent monocyte activator, inhibited IL-8 induction by LIF. On the contrary, IFN-gamma by itself induced MCAF and did not affect the LIF-induced MCAF. These results indicate that LIF released at the site of injury by inducing IL-8 and MCAF can play an important role in recruiting leukocytes and that IFN-gamma can differentially regulate this recruitment.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7655023

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  4 in total

1.  Human adipose mesenchymal stem cells modulate myeloid cells toward an anti-inflammatory and reparative phenotype: role of IL-6 and PGE2.

Authors:  Maitane Ortiz-Virumbrales; Ramón Menta; Laura M Pérez; Ornella Lucchesi; Pablo Mancheño-Corvo; Álvaro Avivar-Valderas; Itziar Palacios; Angel Herrero-Mendez; Wilfried Dalemans; Olga de la Rosa; Eleuterio Lombardo
Journal:  Stem Cell Res Ther       Date:  2020-11-02       Impact factor: 6.832

2.  Antivirulence Bispecific Monoclonal Antibody-Mediated Protection against Pseudomonas aeruginosa Ventilator-Associated Pneumonia in a Rabbit Model.

Authors:  Fábio Aguiar-Alves; Hoan N Le; Vuvi G Tran; Emmanuelle Gras; Trang T T Vu; Oliver X Dong; Josiane Silva Quetz; Lily I Cheng; Li Yu; Bret R Sellman; Charles K Stover; Antonio DiGiandomenico; Binh An Diep
Journal:  Antimicrob Agents Chemother       Date:  2021-12-13       Impact factor: 5.191

3.  New microbicidal functions of tracheal glands: defective anti-infectious response to Pseudomonas aeruginosa in cystic fibrosis.

Authors:  Sonia Bastonero; Yannick Le Priol; Martine Armand; Christophe S Bernard; Martine Reynaud-Gaubert; Daniel Olive; Daniel Parzy; Sophie de Bentzmann; Christian Capo; Jean-Louis Mege
Journal:  PLoS One       Date:  2009-04-28       Impact factor: 3.240

4.  MEDI3902 Correlates of Protection against Severe Pseudomonas aeruginosa Pneumonia in a Rabbit Acute Pneumonia Model.

Authors:  Hoan N Le; Josiane Silva Quetz; Vuvi G Tran; Vien T M Le; Fábio Aguiar-Alves; Marcos G Pinheiro; Lily Cheng; Li Yu; Bret R Sellman; Charles K Stover; Antonio DiGiandomenico; Binh An Diep
Journal:  Antimicrob Agents Chemother       Date:  2018-04-26       Impact factor: 5.191

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.